Anzeige
Meldung des Tages: Breaking News: Kursexplosion 2025 – Rallye 2026?!

Fortress Biotech Aktie News

Aktie
WKN:  A3EWWP ISIN:  US34960Q3074 US-Symbol:  FBIO Branche:  Biotechnologie Land:  USA
3,74 $
+0,07 $
+1,91%
3,1771 € 26.12.25
Depot/Watchlist
Marktkapitalisierung *
147,03 Mio. €
Streubesitz
64,69%
KGV
-0,89
Index-Zuordnung
-

Fortress Biotech News

28.10.25 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortress Biotech Inc. - FBIO
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortress Biotech Inc. - FBIO PR Newswire
23.10.25 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortress Biotech Inc. - FBIO
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortress Biotech Inc. - FBIO PR Newswire
18.10.25 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortress Biotech Inc. - FBIO
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortress Biotech Inc. - FBIO PR Newswire
13.10.25 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortress Biotech Inc. - FBIO
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortress Biotech Inc. - FBIO PR Newswire
08.10.25 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortress Biotech Inc. - FBIO
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortress Biotech Inc. - FBIO PR Newswire
10.03.25 - PR Newswire
CKPT Merger Alert: Checkpoint Shareholders Seeking Money Should Contact Julie & Holleman Regarding Sale to Sun Pharma
CKPT Merger Alert: Checkpoint Shareholders Seeking Money Should Contact Julie & Holleman Regarding Sale to Sun Pharma PR Newswire
09.03.25 - PR Newswire
Sun Pharma to Acquire Checkpoint Therapeutics
Sun Pharma to Acquire Checkpoint Therapeutics PR Newswire
06.01.25 - PR Newswire
Sentynl Therapeutics Announces U.S. FDA Acceptance and Priority Review of New Drug Application for CUTX-101 (Copper Histidinate) Product Candidate for Treatment of Menkes Disease
Sentynl Therapeutics Announces U.S. FDA Acceptance and Priority Review of New Drug Application for CUTX-101 (Copper Histidinate) Product Candidate for Treatment of Menkes ...
06.12.23 - PR Newswire
Sentynl Therapeutics Completes Asset Transfer of CUTX-101 Copper Histidinate Product Candidate for Treatment of Menkes Disease from Cyprium Therapeutics
Sentynl Therapeutics Completes Asset Transfer of CUTX-101 Copper Histidinate Product Candidate for Treatment of Menkes Disease from Cyprium Therapeutics PR Newswire
04.12.23 - PR Newswire
Thinking about buying stock in Johnson & Johnson, Fortress Biotech, MicroStrategy, Neximmune, or ShiftPixy?
Thinking about buying stock in Johnson & Johnson, Fortress Biotech, MicroStrategy, Neximmune, or ShiftPixy? PR Newswire
17.11.23 - PR Newswire
Thinking about buying stock in Coinbase Global, Celsius Holdings, Cadence Design Systems, Coherus Biosciences, or Fortress Biotech?
Thinking about buying stock in Coinbase Global, Celsius Holdings, Cadence Design Systems, Coherus Biosciences, or Fortress Biotech? PR Newswire
06.10.22 - EQS
EQS-News: Fortress Bio’s Portfolio Of Marketed Drugs Could Soon See Three Additions
EQS-News: Fortress Biotech, Inc. Fortress Bio’s Portfolio Of Marketed Drugs Could Soon See Three Additions 06.10.2022 / 14:00 CET/CEST The issuer is solely responsible for the ...
13.10.21 - PR Newswire
Fortress Biotech and Cyprium Therapeutics Announce Positive Clinical Data for CUTX-101, Copper Histidinate, Presented at 2021 American Academy of Pediatrics National Conference & Exhibition
Fortress Biotech and Cyprium Therapeutics Announce Positive Clinical Data for CUTX-101, Copper Histidinate, Presented at 2021 American Academy of Pediatrics National ...
29.09.21 - PR Newswire
Thinking about buying stock in Applied UV, Fortress Biotech, Geovax Labs, Amicus Therapeutics, or Lucid Group?
Thinking about buying stock in Applied UV, Fortress Biotech, Geovax Labs, Amicus Therapeutics, or Lucid Group? PR Newswire
12.04.21 - PR Newswire
Thinking about buying stock in Nuance Communications, GameStop, Evelo Biosciences, Progenity, or Fortress Biotech?
Thinking about buying stock in Nuance Communications, GameStop, Evelo Biosciences, Progenity, or Fortress Biotech? PR Newswire
01.04.21 - PR Newswire
Thinking about buying stock in Jaguar Health, Funko, ChargePoint Holdings, Fortress Biotech, or Lordstown Motors?
Thinking about buying stock in Jaguar Health, Funko, ChargePoint Holdings, Fortress Biotech, or Lordstown Motors? PR Newswire
02.03.21 - PR Newswire
Thinking about buying stock in ConforMIS, Inuvo, Rocket Companies, Fortress Biotech, or Perion Network?
Thinking about buying stock in ConforMIS, Inuvo, Rocket Companies, Fortress Biotech, or Perion Network? PR Newswire
09.01.21 - PR Newswire
ROSEN, A LEADING AND LONGSTANDING LAW FIRM, Reminds Fortress Biotech, Inc. Investors of Important January 26 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm - FBIO
ROSEN, A LEADING AND LONGSTANDING LAW FIRM, Reminds Fortress Biotech, Inc. Investors of Important January 26 Deadline in Securities Class Action; Encourages Investors ...
03.01.21 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fortress Biotech, Inc. of Class Action Lawsuit and Upcoming Deadline - FBIO
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fortress Biotech, Inc. of Class Action Lawsuit and Upcoming Deadline - ...
30.12.20 - PR Newswire
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Fortress Biotech, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Fortress Biotech, Inc. and Encourages Investors with Losses in ...

Newssuche

Videos

newspaper
26.12.25
Viper Strike Strategie Intro
Strategie-​Paket inklusive Live Online-​Schulung am 4.1. JETZT buchbar ... Mehr »
Anzeige

Aktie im Fokus

Breaking News
TempraMed Technologies Ltd
0,566 €
+2,54%
TempraMed Technologies Ltd Chart
Kursexplosion 2025 – Rallye 2026?!
Mehr zur Aktie »